Between 21-25 September 2020, the World Health Organisation (WHO) organised a virtual workshop with key international health partners to map out a plan to boost access to affordable and quality assured insulin and associated devices.
IDF participated in this meeting to provide an update of the global impact of diabetes. Together with the Juvenile Diabetes Research Foundation (JDRF) and NCD Alliance (NCDA), IDF delivered a statement on the need for an action plan to deliver universal and sustainable access to affordable insulin, related supplies and support.
Download the IDF, JDRF and NCDA statement
Image credit: © World Health Organisation (WHO)
